Cesaratto Laura, Vascotto Carlo, Calligaris Sebastian, Tell Gianluca
Department of Biomedical Sciences and Technologies, University of Udine, P.le Kolbe 4, 33100 Udine, Italy.
Ann Hepatol. 2004 Jul-Sep;3(3):86-92.
Oxidative stress is a major pathogenetic event occurring in several liver disorders ranging from metabolic to proliferative ones, and is a major cause of liver damage due to Ischemia/Reperfusion (I/R) during liver transplantation. The main sources of ROS are represented by mitochondria and cytocrome P450 enzymes in the hepatocyte, by Kupffer cells and by neutrophils. Cells are provided with efficient molecular strategies to strictly control the intracellular ROS level and to maintain the balance between oxidant and antioxidant molecules. A cellular oxidative stress condition is determined by an imbalance between the generation of ROS and the antioxidant defense capacity of the cell and can affect major cellular components including lipids, proteins and DNA. Proteins are very important signposts of cellular redox status and through their structure/function modulation, ROS can also influence gene expression profile by affecting intracellular signal transduction pathways. While several enzymatic (such as superoxide dismutase, catalase, glutathione peroxidase) and non enzymatic (such as 4-hydroxynonenal, decrease of glutathione, vitamin E, vitamin C, malondialdehyde) markers of chronic oxidative stress in liver are well known, early protein targets of oxidative injury are yet not well defined. Identification of these markers will enable early detection of liver diseases and will allow monitoring the degree of liver damage, the response to pharmacological therapies and the development of new therapeutic approaches. In the new era of molecular medicine, new proteomics methodologies promise to establish a relationship between pathological hallmarks of disease and protein structural and functional abnormalities in liver disease, thus allowing a better understanding and a more rational therapy on these disorders.
氧化应激是发生在从代谢性到增殖性等多种肝脏疾病中的主要致病事件,也是肝移植期间缺血/再灌注(I/R)导致肝损伤的主要原因。活性氧(ROS)的主要来源包括肝细胞中的线粒体和细胞色素P450酶、库普弗细胞和中性粒细胞。细胞具备有效的分子策略来严格控制细胞内ROS水平,并维持氧化剂和抗氧化剂分子之间的平衡。细胞氧化应激状态取决于ROS生成与细胞抗氧化防御能力之间的失衡,并且会影响包括脂质、蛋白质和DNA在内的主要细胞成分。蛋白质是细胞氧化还原状态的重要标志,通过其结构/功能调节,ROS还可通过影响细胞内信号转导途径来影响基因表达谱。虽然肝脏慢性氧化应激的几种酶促标志物(如超氧化物歧化酶、过氧化氢酶、谷胱甘肽过氧化物酶)和非酶促标志物(如4-羟基壬烯醛、谷胱甘肽减少、维生素E、维生素C、丙二醛)已为人熟知,但氧化损伤的早期蛋白质靶点尚未明确界定。鉴定这些标志物将有助于早期检测肝脏疾病,并能监测肝损伤程度、对药物治疗的反应以及新治疗方法的开发。在分子医学的新时代,新的蛋白质组学方法有望在疾病的病理特征与肝脏疾病中的蛋白质结构和功能异常之间建立联系,从而更好地理解这些疾病并进行更合理的治疗。